ABOUT

Welcome to the SAN SEBASTIAN INTERNATIONAL GENITOURINARY CANCER SUMMIT 2026. We are dedicated to bringing together leading experts, researchers, and healthcare professionals to discuss and exchange cutting-edge perspectives on GU cancers, with a specific focus on bladder, kidney, and prostate cancers. Our summit provides a platform for in-depth discussions, knowledge sharing, and networking opportunities, aiming to drive advancements in the field of genitourinary oncology.

S U M M I T C O - C H A I R S

Meet the key LEADERS behind the SAN SEBASTIAN INTERNATIONAL GENITOURINARY CANCER SUMMIT 2026.

Dr. Andrea Apolo

Conference Chair

Andrea B. Apolo, MD, is an internationally recognized medical oncologist and physician-scientist specializing in bladder and genitourinary cancers. She is a tenured investigator at the U.S. National Institutes of Health and serves as Head of the Bladder Cancer Section at the National Cancer Institute, directing a multidisciplinary GU clinic. Dr. Apolo has led over 35 clinical trials, authored more than 120 peer-reviewed publications, pioneered immunotherapy strategies from first-in-human to phase III studies, received multiple NIH and NCI awards, and is Chair of the ASCO Genitourinary Cancers Symposium (2025–2028).

Dr. Enrique Grande

Conference Chair

Medical Oncology Department Director at Quironsalud Madrid, Spain. Dr. Enrique Grande, MD, PhD, Msc, is focused research on genitourinary and endocrine tumors and actively contributes to the development of the Translational Research and Early Drug Development Unit. Dr. Grande was awarded his PhD for a pharmacokinetic and pharmacodynamic study of tyrosine kinase inhibitors in liver metabolism, and he holds a master’s degree in molecular biology of cancer from the Spanish National Cancer Research Centre (CNIO). Published author of more than 200 manuscripts in peer-reviewed journals, Dr. Grande is also the founder of the Spanish Group of Research on Orphan and Uncommon Tumors (GETHI).